| In € million | 2023 |
| Income statement data | |
| Sales | 7065 |
| Net sales | 6834 |
| Underlying EBITDA | 1618 |
| Underlying EBITDA margin | 23,7% |
| IFRS EBIT | 547 |
| Underlying profit for the period | 756 |
| IFRS profit for the period | 197 |
| Underlying profit attributable to Syensqo share | 752 |
| IFRS profit attributable to Syensqo share | 193 |
| Cash flow data | |
| Capex | 848 |
| Cash conversion | 47,6% |
| FCF | 448 |
| FCF to Syensqo shareholders | 448 |
| Balance sheet data | |
| Net working capital | 1200 |
| Net working capital/sales | 18,7% |
| Underlying net debt | 1584 |
| Perpetual hybrid bonds | 500 |
| IFRS net debt | 1084 |
| IFRS equity | 7608 |
| Equity attributable to non-controlling interests | 42 |
| Underlying leverage ratio | 1,0x |
| Other key data | |
| ROCE | 10,6% |
| Research & innovation | 340 |
| Research & innovation intensity | 5% |